Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
565-02-006 ISMRM Abstract

The Utility of Sodium Inversion Recovery MR Imaging to Identify Astrocytoma, IDH-mutant

Accepted
Koji Yamashita 1, Makoto Obara2, Kazufumi Kikuchi3, Daichi Momosaka3, Masaoki Kusunoki3, Yasutomo Katsumata2, Marc Van Cauteren2, Kousei Ishigami3
1Department of Molecular Imaging & Diagnosis, Kyushu University, Fukuoka, Japan
2Philips Japan, Tokyo, Japan
3Department of Clinical Radiology, Kyushu University, Fukuoka, Japan
Presenting Author: Koji Yamashita

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. 1. Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008; 321:1807-1812. PMID: 18772396 [pmid]
2. 2. Patel SH, Poisson LM, Brat DJ, et al. T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project. Clin Cancer Res. 2017; 23:6078-6085. PMID: 28751449 [pmid]
3. 3. Jain R, Johnson DR, Patel SH, et al. "Real world" use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomas. Neuro Oncol. 2020; 22:936-943. PMID: 32064507 [pmid]
4. 4. Kinoshita M, Arita H, Takahashi M, et al. Impact of Inversion Time for FLAIR Acquisition on the T2-FLAIR Mismatch Detectability for IDH-Mutant, Non-CODEL Astrocytomas. Front Oncol. 2021; 10:596448. PMID: 33520709 [pmid]
5. 5. Park SI, Suh CH, Guenette JP, et al. The T2-FLAIR mismatch sign as a predictor of IDH-mutant, 1p/19q-noncodeleted lower-grade gliomas: a systematic review and diagnostic meta-analysis. Eur Radiol. 2021; 31:5289-5299. PMID: 33409784 [pmid]
6. 6. Gast LV, Platt T, Nagel AM, Gerhalter T. Recent technical developments and clinical research applications of sodium (23Na) MRI. Prog Nucl Magn Reson Spectrosc. 2023; 138-139:1-51. PMID: 38065665 [pmid]
7. 7. Nagel AM, Bock M, Hartmann C, et al. The potential of relaxation-weighted sodium magnetic resonance imaging as demonstrated on brain tumors. Invest Radiol. 2011; 46:539-547. PMID: 21577129 [pmid]
8. 8. Deguchi S, Oishi T, Mitsuya K, et al. Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomas. Sci Rep. 2020; 10:10113. PMID: 32572107 [pmid]

Cite this abstract